{
    "clinical_study": {
        "@rank": "161318", 
        "arm_group": {
            "arm_group_label": "induced changes in hemodynamics", 
            "arm_group_type": "Experimental", 
            "description": "Twenty-five patients are planned enrolled. After induction of anesthesia, insertion of the PAC and the CardioQ probe, the patient are placed in the following successive positions: a) supine, b) head-down tilt, c) head-up tilt, d) supine, e) supine with phenylephrine administration f) pace heart rate 80 bpm, g) pace heart rate 110 bpm. CO are measured simultaneously using the CardioQ and thermodilution technique."
        }, 
        "brief_summary": {
            "textblock": "Minimal invasive monitoring systems of central hemodynamics are gaining increasing\n      popularity. The present study investigates the precision of the esophageal doppler (CardioQ)\n      derived cardiac output  and its agreement with pulmonary artery catheter thermodilution (PAC\n      TD) for measuring CO during steady state and with induced hemodynamic changes in patients\n      scheduled for elective cardiac surgery."
        }, 
        "brief_title": "CardioQ vs Thermodilution Measurements of Cardiac Output", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Comparison of CardioQ and Thermodilution Derived Cardiac Output Measurements", 
        "detailed_description": {
            "textblock": "Twenty-five patients are planned to be enrolled. After induction of anesthesia, insertion of\n      the PAC and the esophageal-doppler probe, the patient are placed in the following successive\n      positions: a) supine, b) head-down tilt, c) head-up tilt, d) supine, e) supine with\n      phenylephrine administration f) pace heart rate 80 bpm, g) pace heart rate 110 bpm, and CO\n      are measured simultaneously using the CardioQ and PAC TD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients scheduled for elective coronary artery bypass grafting (CABG), who are in\n             stable sinus rhythm, who have a left ventricular ejection fraction > 0.40 measured by\n             transthoracic echocardiography, and who have no significant valve pathology\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744795", 
            "org_study_id": "H-3-2012-063"
        }, 
        "intervention": {
            "arm_group_label": "induced changes in hemodynamics", 
            "description": "Twenty-five patients are planned enrolled. After induction of anesthesia, insertion of the PAC and the CardioQ probe, the patient are placed in the following successive positions: a) supine, b) head-down tilt, c) head-up tilt, d) supine, e) supine with phenylephrine administration f) pace heart rate 80 bpm, g) pace heart rate 110 bpm. CO are measured simultaneously using the TEE and thermodilution technique.", 
            "intervention_name": "induced changes in hemodynamics", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cardiac output", 
            "thermodilution", 
            "esophageal doppler", 
            "trending ability"
        ], 
        "lastchanged_date": "June 17, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "state": "Capital region", 
                        "zip": "2100"
                    }, 
                    "name": "Rigshospitalet, University of Copenhagen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Department of Cardiothoracic anesthesiology; Rigshospitalet"
                }
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "official_title": "Comparison of CardioQ and Pulmonary Artery Thermodilution Derived Cardiac Output Measurements", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Scientific-Ethics Committee of the Capital Region", 
                "Denmark: Regional data-registry unit; Rigshospitalet"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Data are collected for each patient in the perioperative period. Patients are followed in the first 24 hours. Data will after inclusion of the last data be analysed and appropiate statistics aplied.", 
            "measure": "Agreement of cardiac output determined with CardioQ, compared with thermodilution", 
            "safety_issue": "No", 
            "time_frame": "Data are collected in the perioperative period (30min.)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744795"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Hasse Moller-Sorensen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hasse Moller-Sorensen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}